Glycyrrhizin derivative inhibits eotaxin 1 production via STAT6 in human lung fibroblasts

International Immunopharmacology

Volumn 6, Issue 3, 2006, Pages 369-375

  Matsui, Sachiko ^a,b   Sonoda, Yoshiko ^b   Sekiya, Takashi ^c   Aizu Yokota, Eriko ^b   Kasahara, Tadashi ^b  

^a Minophagen Pharmaceutical Co Ltd   (Japan)

^b KEIO UNIVERSITY   (Japan)

^c UNIVERSITY OF TOKYO   (Japan)

Author keywords

Eotaxin 1; Glycyrrhizin derivatives; Human lung fibroblast; Nuclear factor kappa B; Signal transducer and activator of transcription 6

Indexed keywords

(3 BETA [(2 O BETA DEXTRO GLUCOPYRANURONOSYL BETA DEXTRO GLUCOPYRANURONOSYL)OXY] OLEAN 11,13(18) DIEN 30 OL); 18 BETA GLYCYRRHIZIN; EOTAXIN; GLYCYRRHIZIC ACID DERIVATIVE; I KAPPA B ALPHA; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; MESSENGER RNA; RECOMBINANT INTERLEUKIN 4; RECOMBINANT TUMOR NECROSIS FACTOR ALPHA; STAT6 PROTEIN; UNCLASSIFIED DRUG;

ARTICLE; CONTROLLED STUDY; CYTOSOL; CYTOTOXICITY; DRUG INHIBITION; GEL MOBILITY SHIFT ASSAY; GENE ACTIVATION; HUMAN; HUMAN CELL; LUNG FIBROBLAST; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN DEGRADATION; PROTEIN PHOSPHORYLATION; PROTEIN STABILITY; SIGNAL TRANSDUCTION;

CELLS, CULTURED; CHEMOKINE CCL11; ELECTROPHORETIC MOBILITY SHIFT ASSAY; FIBROBLASTS; GLYCYRRHIZIC ACID; HUMANS; LUNG; NF-KAPPA B; PROMOTER REGIONS, GENETIC; RNA STABILITY; RNA, MESSENGER; STAT6 TRANSCRIPTION FACTOR;

EID: 31044450232     PISSN: 15675769     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.intimp.2005.08.025     Document Type: Article

References (28)

1. P.J. Jose, D.A. Griffiths-Johnson, P.D. Collins, D.T. Walsh, R. Moqbel, and N.F. Totty Eotaxin: a potent eosinophil chemoattractant cytokine detected in a guinea pig model of allergic airways inflammation J Exp Med 179 1994 881 887
2. L.M. Teran, M. Mochizuki, J. Bartels, E.L. Valencia, T. Nakajima, and K. Hirai Th1-and Th2-type cytokines regulate the expression and production of eotaxin and RANTES by human lung fibroblasts Am J Respir Cell Mol Biol 20 1999 777 786
3. M. Miyamasu, T. Nakajima, Y. Misaki, S. Izumi, N. Tsuno, and T. Kasahara Dermal fibroblasts represent a potent major source of human eotaxin: in vitro production and cytokine-mediated regulation Cytokine 11 1999 751 758
4. C. Stellato, S. Matsukura, A. Fal, J. White, L.A. Beck, and D. Proud Differential regulation of epithelial-derived C-C chemokine expression by IL-4 and the glucocorticoid budesonide J Immunol 163 1999 5624 5632
5. T. Sekiya, M. Miyamasu, M. Imanishi, H. Yamada, T. Nakajima, and M. Yamaguchi Inducible expression of a Th2-type CC chemokine thymus- and activation-regulated chemokine by human bronchial epithelial cells J Immunol 165 2000 2205 2213
6. A. Komiya, H. Nagase, H. Yamada, T. Sekiya, M. Yamaguchi, and Y. Sano Concerted expression of eotaxin-1, eotaxin-2, and eotaxin-3 in human bronchial epithelial cells Cell Immunol 225 2003 91 100
7. S. Matsukura, C. Stellato, J.R. Plitt, C. Bickel, K. Miura, and S.N. Georas Activation of eotaxin gene transcription by NF-kappa B and STAT6 in human airway epithelial cells J Immunol 163 1999 6876 6883
8. J. Hoeck, and M. Woisetschlager STAT6 mediates eotaxin-1 expression in IL-4 or TNF-alpha-induced fibroblasts J Immunol 166 2001 4507 4515
9. M. Nie, L. Corbett, A.J. Knox, and L. Pang Differential regulation of chemokine expression by peroxisome proliferator-activated receptor gamma agonists: interactions with glucocorticoids and beta2-agonists J Biol Chem 280 2005 2550 2561
10. K. Takamura, Y. Nasuhara, M. Kobayashi, T. Betsuyaku, Y. Tanino, and I. Kinoshita Retinoic acid inhibits interleukin-4-induced eotaxin production in a human bronchial epithelial cell line Am J Physiol Lung Cell Mol Physiol 286 2004 77 85
11. S. Matsukura, F. Kokubu, M. Kurokawa, M. Kawaguchi, H. Kuga, and K. Ieki Molecular mechanisms of repression of eotaxin expression with fluticasone propionate in airway epithelial cells Int Arch Allergy Immunol 134 2004 12 20
12. S. Matsui, H. Matsumoto, Y. Sonoda, K. Ando, E. Aizu-Yokota, and T. Sato Glycyrrhizin and related compounds down-regulate production of inflammatory chemokines IL-8 and eotaxin 1 in a human lung fibroblast cell line Int Immunopharmacol 4 2004 1633 1644
13. Y. Arase, K. Ikeda, N. Murashima, K. Chayama, A. Tsubota, and I. Koida The long term efficacy of glycyrrhizin in chronic hepatitis C patients Cancer 79 1997 1494 1500
14. M. Kimura, H. Inoue, K. Hirabayashi, H. Natsume, and M. Ogihara Glycyrrhizin and some analogues induce growth of primary cultured adult rat hepatocytes via epidermal growth factor receptors Eur J Pharmacol 431 2001 151 161
15. Y. Shimoyama, K. Hirabayashi, H. Matsumoto, T. Sato, S. Shibata, and H. Inoue Effects of glycyrrhetinic acid derivatives on hepatic and renal 11beta-hydroxysteroid dehydrogenase activities in rats J Pharm Pharmacol 55 2003 811 817
16. E. Gumpricht, R. Dahl, M.W. Devereaux, and R.J. Sokol Licorice compounds glycyrrhizin and 18beta-glycyrrhetinic acid are potent modulators of bile acid-induced cytotoxicity in rat hepatocytes J Biol Chem 280 2005 10556 10563
17. Z. Yu, Y. Ohtaki, K. Kai, T. Sasano, H. Shimauchi, and T. Yokochi Critical roles of platelets in lipopolysaccharide-induced lethality: effects of glycyrrhizin and possible strategy for acute respiratory distress syndrome Int Immunopharmacol 5 2005 571 580
18. M. Takei, M. Kobayashi, X.D. Li, R.B. Pollard, and F. Suzuki Glycyrrhizin inhibits R5 HIV replication in peripheral blood monocytes treated with 1-methyladenosine Pathobiology 72 2005 117 123
19. Y. Sonoda, S. Watanabe, Y. Matsumoto, E. Aizu-Yokota, and T. Kasahara FAK is the upstream signal protein of the phosphatidylinositol 3-kinase-Akt survival pathway in hydrogen peroxide-induced apoptosis of a human glioblastoma cell line J Biol Chem 274 1999 10566 10570
20. Y. Sonoda, Y. Matsumoto, M. Funakoshi, D. Yamamoto, S.K. Hanks, and T. Kasahara Anti-apoptotic role of focal adhesion kinase (FAK). Induction of inhibitor-of-apoptosis proteins and apoptosis suppression by the overexpression of FAK in a human leukemic cell line, HL-60 J Biol Chem 275 2000 16309 16315
21. M. Funakoshi, K. Tago, Y. Sonoda, S. Tominaga, and T. Kasahara A MEK inhibitor, PD98059 enhances IL-1-induced NF-kappaB activation by the enhanced and sustained degradation of IkappaBalpha Biochem Biophys Res Commun 283 2001 248 254
22. D. Ichikawa, A. Matsui, M. Imai, Y. Sonoda, and T. Kasahara Effect of various catechins on the IL-12p40 production by murine peritoneal macrophages and a macrophage cell line J774.1 Biol Pharm Bull 27 2004 1353 1358
23. E. Pfitzner, S. Kliem, D. Baus, and C.M. Litterst The role of STATs in inflammation and inflammatory diseases Curr Pharm Des 10 2004 2839 2850
24. A.S. Baldwin Jr. The NF-kappa B and I kappa B proteins: new discoveries and insights Annu Rev Immunol 14 1996 649 683
25. T. Sato, R. Saito, T. Jinushi, T. Tsuji, J. Matsuzaki, and T. Koda IFN-gamma-induced SOCS-1 regulates STAT6-dependent eotaxin production triggered by IL-4 and TNF-alpha Biochem Biophys Res Commun 314 2004 468 475
26. U. Atasoy, S.L. Curry, I. Lopez de Silanes, A.B. Shyu, V. Casolaro, and M. Gorospe Regulation of eotaxin gene expression by TNF-alpha and IL-4 through mRNA stabilization: involvement of the RNA-binding protein HuR J Immunol 171 2003 4369 4378
27. K. Suzuki, H. Nakajima, K. Ikeda, Y. Maezawa, A. Suto, and H. Takatori IL-4-Stat6 signaling induces tristetraprolin expression and inhibits TNF-alpha production in mast cells J Exp Med 198 2003 1717 1727
28. A. Mathew, J.A. MacLean, E. DeHaan, A.M. Tager, F.H. Green, and A.D. Luster Signal transducer and activator of transcription 6 controls chemokine production and T helper cell type 2 cell trafficking in allergic pulmonary inflammation J Exp Med 193 2001 1087 1096